Development of Lyophilised Eudragit® Retard Nanoparticles for the Sustained Release of Clozapine via Intranasal Administration.
Lombardo R, Ruponen M, Rautio J, Ghelardini C, Di Cesare Mannelli L, Calosi L, Bani D, Lampinen R, Kanninen KM, Koivisto AM, Penttilä E, Löppönen H, Pignatello R.
Lombardo R, et al. Among authors: rautio j.
Pharmaceutics. 2023 May 21;15(5):1554. doi: 10.3390/pharmaceutics15051554.
Pharmaceutics. 2023.
PMID: 37242796
Free PMC article.